HOW YOU CAN GET INVOLVED
HERPES - Treatment With Transfer Factor
Purchase Transfer Factor
Careers With Transfer Factor
Media Videos Etc.
[Excerpts from "Natural Immune Booster Transfer Factor" by mircobiologist William J. Hennen Ph.D.]
"The very presence of hepatitis-specific Transfer Factors protects a recipient from the disease. The use of Transfer Factor, whether from bovine or placental origin, has been shown to be highly effective and do not result in any cases of viral disease or flare up of existing disease. In a study of hepatitis-specific Transfer Factor derived from bovine sources, 52 cases of chronic, persistent, active hepatitis with some cirrhosis after hepatitis were examined. Symptoms improved or disappeared in all patients. It should be noted that the authors made special note that colds and fatique were especially diminished. Immunological profiles also returned to normal. In the case of the placental-derived Transfer Factor, 260 cases of hepatitis B were tested and a 100 percent clinical recovery was reported with no side effects. Immunological profiles were normalized in approximately half of the individuals at the end of the observation period.
Hepatitis is a severe problem in China---approximately 33 percent of the population suffer from some form of the disease. It is not surprising therefore that much of the work with hepatitis-specific Transfer Factor has been done in the Orient. Recently four patents have been issued to Chinese researchers for preparations of Transfer Factor to treat hepatitis A and B virus infections. A paper describing the isolation and identification of a hepatitis B specific Transfer Factor has also been published by researchers from Tianjin Medical University. It has been reported that 6 million Chinese currently take hepatitis-specific Transfer Factor as a preventative measure."
****
EVALUATION OF SPECIFIC TRANSFER FACTORS IN THE TREATMENT OF TWO PATIENTS WITH HEPATITIS-C. TWO CASE REPORTS.
AUTHORS: *G. Langham-Mcnally, C.C. N., M.H. Dopson
Institution: Chisolm Biological Laboratories, Aiken, Sc, U.S.A.
Abstracts:
Two patients with mild elevation of transaminase who were subsequently identified through IgG by EIA and PCR serological studies as having Hepatitis-C and who exhibited chronic exhaustion and general malaise, were intially given Vitamin C intravenous on a weekly schedule until their oral preparation of specific transfer factor was completed. The intravenenous solutions were discontinued at the time the transfer factor was begun. At the time of initial administration, the patients were able to return to work and participate in moderate exercise. At four weeks they resumed extended travel and their daily routine. At two months, transaminase,albumin, neutrophils, and lymphocytes all dropped from the initial value of over 4 million to 900,000. This is a continuing study and serology studies will be performed at three month intervals, for two years. The next laboratory results are due February 12, 1999.
References and Medical Studies